Blood test to predict multiple sclerosis flare-ups
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at a blood marker called TWEAK to see if it can signal when multiple sclerosis or its first symptoms might flare up again. If you join, your blood would be checked at regular visits to help predict future inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a first event of inflammation in the brain, spinal cord, or optic nerve that could be multiple sclerosis, or you already have a confirmed MS diagnosis.
- Your diagnosis fits the 2017 McDonald criteria (a standard way doctors diagnose MS).
- You are not pregnant or breastfeeding.
- You are able to give consent and are covered by a health insurance or social security program.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This study checks specific proteins in spinal fluid to see whether they can predict how multiple sclerosis (or related symptoms like optic neuritis) may go over time. It may help doctors better estimate prognosis using results from tests you may already be having.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
This study looks at tiny particles in the blood that may show how much nerve damage has happened. It aims to find a simple blood test to help doctors understand and monitor conditions like multiple sclerosis and stroke.
This study measures blood markers (from a serum blood sample) to see how nerve and brain changes relate to MS disease activity and disability over time. It may help researchers better monitor MS, especially in people followed in the OFSEP program.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.